Dianthus Therapeutics DNTH
NASDAQ DNTH
$89.30 +0.49 (+0.55%)
At close: Nov 11, 2026 · 4:00 PM EST

Dianthus Therapeutics (DNTH) Amortization of Deferred Charges (2020 - 2022)

Updated

Analysis

Dianthus Therapeutics (DNTH) Amortization of Deferred Charges (2020 - 2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Dianthus Therapeutics 5.00 Bn 4.95 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 -98,000.00
Sep 30, 2022 78,000.00
Jun 30, 2022 113,000.00
Mar 31, 2022 115,000.00
Dec 31, 2021 78,000.00
Sep 30, 2021 193,000.00
Jun 30, 2021 221,000.00
Mar 31, 2021 216,000.00
Dec 31, 2020 68,000.00
Sep 30, 2020 48,000.00
Jun 30, 2020 49,000.00
Mar 31, 2020 14,000.00
API Access

Dianthus Therapeutics Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=DNTH&period=max&api_key=YOUR_API_KEY